Skip to main content
logo
Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
23.88
+0.37 (1.57%)
At close: Aug 21, 2026, 4:00 PM EDT
24.02
+0.14 (0.59%)
After-hours: Aug 21, 2026, 7:45 PM EDT

Tango Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
4,0261,1933321,010639958
Market Cap Growth
436.14%259.50%-67.13%57.94%-33.25%-
Enterprise Value
3,0441,07576689287461
Last Close Price
23.888.863.099.907.2510.94

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
74.8319.137.8927.6425.7225.86
PB Ratio
3.923.451.663.992.562.78
P/TBV Ratio
3.933.451.663.992.562.78

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
56.5817.241.8118.8711.5312.45

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.100.180.150.170.00
Net Debt / Equity Ratio
-0.96-0.89-1.11-1.18-1.30-1.40
Net Debt / EBITDA Ratio
7.312.841.552.672.978.44
Net Debt / FCF Ratio
6.812.211.672.492.787.88
Asset Turnover
0.080.170.120.090.050.11
Quick Ratio
49.9515.836.767.336.6311.98
Current Ratio
50.8216.326.987.546.7612.10
Return on Equity (ROE)
-21.34%-37.23%-57.58%-40.49%-36.41%-30.38%
Return on Assets (ROA)
-12.99%-19.45%-25.31%-17.01%-14.82%-10.28%
Return on Capital Employed (ROCE)
-12.90%-29.50%-52.30%-32.00%-29.20%-12.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.07%-8.51%-39.26%-10.08%-16.92%-6.08%
FCF Yield
-3.58%-11.73%-39.85%-11.84%-18.27%-6.41%
Buyback Yield / Dilution
-22.81%-6.35%-15.50%-7.69%-41.40%-94.50%
SEC Filings: 10-K · 10-Q